{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:19:43Z","timestamp":1776788383810,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11596-024-2828-8","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:03:26Z","timestamp":1708686206000},"page":"232-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Secoemestrin C Ameliorates Psoriasis-like Skin Inflammation in Mice by Suppressing the TNF-\u03b1\/NF-\u03baB Signaling Pathway"],"prefix":"10.1007","volume":"44","author":[{"given":"Zhi-bin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"issue":"2","key":"2828_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DPM, Griffiths CEM, et al. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol, 2013,133(2):377\u2013385","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2828_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol, 2017,31(2):205\u2013212","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"18","key":"2828_CR3","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","volume":"20","author":"K Kamiya","year":"2019","unstructured":"Kamiya K, Kishimoto M, Sugai J, et al. Risk factors for the development of psoriasis. Int J Mol Sci, 2019,20(18):4347","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2828_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","volume":"80","author":"SB Kaushik","year":"2019","unstructured":"Kaushik SB, Lebwohl MG. Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol, 2019,80(1):27\u201340","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2828_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/187221309787158399","volume":"3","author":"D Tsuruta","year":"2009","unstructured":"Tsuruta D. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov, 2009,3(1):40\u201348","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"20","key":"2828_CR6","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.3390\/ijms21207488","volume":"21","author":"M Tokuyama","year":"2020","unstructured":"Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci, 2020,21(20):7488","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2828_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EHS Choy","year":"2001","unstructured":"Choy EHS, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med, 2001,344(12):907\u2013916","journal-title":"N Engl J Med"},{"issue":"2","key":"2828_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0923-1811(00)00167-5","volume":"26","author":"H Duan","year":"2001","unstructured":"Duan H, Koga T, Kohda F, et al. Interleukin-8-positive neutrophils in psoriasis. J Dermatol Sci, 2001,26(2):119\u2013124","journal-title":"J Dermatol Sci"},{"issue":"5","key":"2828_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1067\/mai.2001.114707","volume":"107","author":"ML Giustizieri","year":"2001","unstructured":"Giustizieri ML, Mascia F, Frezzolini A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol, 2001,107(5):871\u2013877","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"2828_CR10","first-page":"3389","volume":"12","author":"X Tan","year":"2020","unstructured":"Tan X, Sun L, Li Q, et al. Secoemestrin C inhibits activation of NKT\/conventional T cells and protects against concanavalin A-induced autoimmune hepatitis in mice. Am J Transl Res, 2020,12(7):3389\u20133401","journal-title":"Am J Transl Res"},{"issue":"2","key":"2828_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1046\/j.1523-1747.2001.01249.x","volume":"116","author":"M Komine","year":"2001","unstructured":"Komine M, Rao LS, Freedberg IM, et al. Interleukin-1 induces transcription of keratin K6 in human epidermal keratinocytes. J Invest Dermatol, 2001,116(2):330\u2013338","journal-title":"J Invest Dermatol"},{"issue":"5","key":"2828_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/1523-1747.ep12371803","volume":"107","author":"R Gillitzer","year":"1996","unstructured":"Gillitzer R, Ritter U, Spandau U, et al. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol, 1996,107(5):778\u2013782","journal-title":"J Invest Dermatol"},{"issue":"Suppl2","key":"2828_CR13","first-page":"ii18","volume":"64","author":"RG Langley","year":"2005","unstructured":"Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis, 2005,64(Suppl 2):ii18\u201323; discussion ii24\u201315","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"2828_CR14","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.3390\/ijms222312793","volume":"22","author":"R Singh","year":"2021","unstructured":"Singh R, Koppu S, Perche PO, et al. The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. Int J Mol Sci, 2021,22(23):12793","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2828_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.33549\/physiolres.930816","volume":"55","author":"X Shan","year":"2006","unstructured":"Shan X, Chen L, Cao M, et al. Effects of human soluble BAFF synthesized in Escherichia coli on CD4+ and CD8+ T lymphocytes as well as NK cells in mice. Physiol Res, 2006,55(3):301\u2013307","journal-title":"Physiol Res"},{"issue":"3","key":"2828_CR16","first-page":"367","volume":"22","author":"Y Li","year":"2007","unstructured":"Li Y, Li X F, Ma Y, et al. Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy. Cancer Biother Radiopharm, 2007,22(3):367\u2013373","journal-title":"Cancer Biother Radiopharm"},{"key":"2828_CR17","doi-asserted-by":"publisher","first-page":"119630","DOI":"10.1016\/j.lfs.2021.119630","volume":"278","author":"R Zhang","year":"2021","unstructured":"Zhang R, Wang YH, Shi X, et al. Sortilin regulates keratinocyte proliferation and apoptosis through the PI3K-AKT signaling pathway. Life Sci, 2021,278: 119630","journal-title":"Life Sci"},{"issue":"3","key":"2828_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell, 2008,132(3):344\u2013362","journal-title":"Cell"},{"issue":"1","key":"2828_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Y Cai","year":"2019","unstructured":"Cai Y, Xue F, Quan C, et al. A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol, 2019,139(1):146\u2013156","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2828_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.intimp.2015.04.019","volume":"26","author":"JY Su","year":"2015","unstructured":"Su JY, Luo X, Zhang XJ, et al. Immunosuppressive activity of pogostone on T cells: Blocking proliferation via S phase arrest. Int Immunopharmacol, 2015,26(2):328\u2013337","journal-title":"Int Immunopharmacol"},{"key":"2828_CR21","doi-asserted-by":"publisher","first-page":"115124","DOI":"10.1016\/j.jep.2022.115124","volume":"292","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang Y, Chen X, et al. Khasianine ameliorates psoriasis-like skin inflammation and represses TNF-\u03b1\/NF-\u03baB axis mediated transactivation of IL-17A and IL-33 in keratinocytes. J Ethnopharmacol, 2022,292:115124","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"2828_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/cei.13141","volume":"193","author":"A Campanati","year":"2018","unstructured":"Campanati A, Orciani M, Sorgentoni G, et al. Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells. Clin Exp Immunol, 2018,193(2):234\u2013240","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2828_CR23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s12094-017-1774-3","volume":"20","author":"C Yang","year":"2018","unstructured":"Yang C, Zhang J, Ding M, et al. Ki67 targeted strategies for cancer therapy. Clin Transl Oncol, 2018,20(5):570\u2013575","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"2828_CR24","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/bjd.13715","volume":"172","author":"KL Goff","year":"2015","unstructured":"Goff KL, Karimkhani C, Boyers LN, et al. The global burden of psoriatic skin disease. Br J Dermatol, 2015,172(6):1665\u20131668","journal-title":"Br J Dermatol"},{"issue":"7","key":"2828_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00535-012-0678-9","volume":"48","author":"A Campanati","year":"2013","unstructured":"Campanati A, Ganzetti G, Sario AD, et al. The effect of etanercept on hepatic fibrosis risk in patients with nonalcoholic fatty liver disease, metabolic syndrome, and psoriasis. J Gastroenterol, 2013,48(7):839\u2013846","journal-title":"J Gastroenterol"},{"issue":"12","key":"2828_CR26","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.2337\/db13-0138","volume":"62","author":"E Bach","year":"2013","unstructured":"Bach E, Nielsen RR, Vendelbo MH, et al. Direct effects of TNF-a on local fuel metabolism and cytokine levels in the placebo-controlled, bilaterally infused human leg: increased insulin sensitivity, increased net protein breakdown, and increased IL-6 release. Diabetes, 2013,62(12):4023\u20134029","journal-title":"Diabetes"},{"issue":"2","key":"2828_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso EH, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther, 2008,117(2):244\u2013279","journal-title":"Pharmacol Ther"},{"issue":"4","key":"2828_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1586\/ecp.11.28","volume":"4","author":"T Vergou","year":"2011","unstructured":"Vergou T, Moustou AE, Sfikakis PP, et al. Pharmacodynamics of TNF-\u03b1 inhibitors in psoriasis. Expert Rev Clin Pharmacol, 2011,4(4):515\u2013523","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"2828_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","volume":"119","author":"BB Aggarwal","year":"2012","unstructured":"Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood, 2012,119(3):651\u2013665","journal-title":"Blood"},{"issue":"5","key":"2828_CR30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/ijc.31407","volume":"143","author":"GS Calip","year":"2018","unstructured":"Calip GS, Patel PR, Adimadhyam S, et al. Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions. Int J Cancer, 2018,143(5):1062\u20131071","journal-title":"Int J Cancer"},{"issue":"1","key":"2828_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/rheumatology\/key241","volume":"58","author":"KM Fagerli","year":"2019","unstructured":"Fagerli KM, Kearsley-Fleet L, Mercer LK, et al. Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford), 2019,58(1):80\u201385","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2828_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","volume":"25","author":"LM Sedger","year":"2014","unstructured":"Sedger LM, McDermott MF. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants-past, present and future. Cytokine Growth Factor Rev, 2014,25(4):453\u2013472","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2828-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2828-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2828-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:35:21Z","timestamp":1708688121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2828-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2828"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2828-8","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}